IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...

A new study of female Medicare beneficiaries reveals that vulvar lichen sclerosus affects 7 out of every 1,000 women aged 65 and older, significantly higher than rates seen in younger populations. The ...

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...

Older women with vulvar lichen sclerosus are more likely to develop a common type of vulvar cancer if left untreated but are likely underdiagnosed, suggesting that more counseling and regular skin ...

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...